Table 1.
Demographic and psychometric data.
| SP (n = 18) | HC (n = 18) | SP vs. HC | ||
|---|---|---|---|---|
| Measure | Mean (SD) | Mean (SD) | T-score | p-value |
| Age | 35.33 (12.49) | 34.10 (13.4) | 0.318 | 0.75 |
| Sex (m/f) | 9/9 | 9/9 | ||
| PANSS-Total | 76.44 (18.45) | 30.10 (0.66) | 11.23 | <0.001* |
| PANSS-Positive | 18.06 (5.74) | 6.95 (0.23) | 8.57 | <0.001* |
| PANSS-Negative | 19.94 (8.11) | 6.90 (0.44) | 7.08 | <0.001* |
| GAF | 41.50 (11.55) | 99.50 (1.12) | −22.46 | <0.001* |
| CPZ | 466.72 (440.49) | |||
Two-sample t-tests for age and psychometric tests; *significant for p < 0.05. Abbreviations: SP, patients with schizophrenia during acute psychosis; HC, healthy control group; PANSS, Positive and Negative Syndrome Scale; GAF, Global Assessment of Functioning Scale; CPZ, chlorpromazine equivalent dose.